- Home
- ANVS vs SNCR Comparison
ANVS vs SNCR Comparison
Compare ANVS & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- SNCR
- Stock Information
- Founded
- ANVS 2008
- SNCR 2000
- Country
- ANVS United States
- SNCR United States
- Employees
- ANVS N/A
- SNCR N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- SNCR EDP Services
- Sector
- ANVS Health Care
- SNCR Technology
- Exchange
- ANVS Nasdaq
- SNCR Nasdaq
- Market Cap
- ANVS 110.4M
- SNCR 137.5M
- IPO Year
- ANVS 2020
- SNCR 2006
- Fundamental
- Price
- ANVS $9.57
- SNCR $11.25
- Analyst Decision
- ANVS Strong Buy
- SNCR
- Analyst Count
- ANVS 6
- SNCR 0
- Target Price
- ANVS $29.67
- SNCR N/A
- AVG Volume (30 Days)
- ANVS 341.4K
- SNCR 81.2K
- Earning Date
- ANVS 11-06-2024
- SNCR 11-12-2024
- Dividend Yield
- ANVS N/A
- SNCR N/A
- EPS Growth
- ANVS N/A
- SNCR N/A
- EPS
- ANVS N/A
- SNCR N/A
- Revenue
- ANVS N/A
- SNCR $167,615,000.00
- Revenue This Year
- ANVS N/A
- SNCR $7.76
- Revenue Next Year
- ANVS N/A
- SNCR $5.83
- P/E Ratio
- ANVS N/A
- SNCR N/A
- Revenue Growth
- ANVS N/A
- SNCR 33.39
- 52 Week Low
- ANVS $4.53
- SNCR $2.70
- 52 Week High
- ANVS $22.49
- SNCR $15.46
- Technical
- Relative Strength Index (RSI)
- ANVS 58.70
- SNCR 43.11
- Support Level
- ANVS $9.00
- SNCR $10.45
- Resistance Level
- ANVS $10.54
- SNCR $11.44
- Average True Range (ATR)
- ANVS 0.81
- SNCR 0.57
- MACD
- ANVS 0.12
- SNCR -0.06
- Stochastic Oscillator
- ANVS 74.57
- SNCR 31.58
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
About SNCR Synchronoss Technologies Inc.
Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.